South San Francisco, CA1 Active Studies

Atopic Dermatitis Clinical Trials in South San Francisco, CA

Find 1 actively recruiting atopic dermatitis clinical trials in South San Francisco, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
200
Enrolling

Recruiting Atopic Dermatitis Studies in South San Francisco

About Atopic Dermatitis Clinical Trials in South San Francisco

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 1 atopic dermatitis clinical trials recruiting participants in South San Francisco, CA. These studies are seeking a combined 200 participants. Research is being sponsored by Corvus Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in South San Francisco — FAQ

Are there atopic dermatitis clinical trials in South San Francisco?

Yes, there are 1 atopic dermatitis clinical trials currently recruiting in South San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in South San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the South San Francisco research site will contact you about next steps.

Are clinical trials in South San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many South San Francisco studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 1 active trials in South San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated October 16, 2026 from ClinicalTrials.gov